Jukić, A.; Pavan, J.; Đapic Ivančić, B.; Kalauz, M.; Kasalica Žužul, R.; Jukić, T.
RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review. J. Clin. Med. 2025, 14, 6093.
https://doi.org/10.3390/jcm14176093
AMA Style
Jukić A, Pavan J, Đapic Ivančić B, Kalauz M, Kasalica Žužul R, Jukić T.
RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review. Journal of Clinical Medicine. 2025; 14(17):6093.
https://doi.org/10.3390/jcm14176093
Chicago/Turabian Style
Jukić, Anđela, Josip Pavan, Biljana Đapic Ivančić, Miro Kalauz, Rajka Kasalica Žužul, and Tomislav Jukić.
2025. "RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review" Journal of Clinical Medicine 14, no. 17: 6093.
https://doi.org/10.3390/jcm14176093
APA Style
Jukić, A., Pavan, J., Đapic Ivančić, B., Kalauz, M., Kasalica Žužul, R., & Jukić, T.
(2025). RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review. Journal of Clinical Medicine, 14(17), 6093.
https://doi.org/10.3390/jcm14176093